Page last updated: 2024-10-19

niacin and Ovarian Neoplasms

niacin has been researched along with Ovarian Neoplasms in 3 studies

Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kudo, K1
Nomura, M1
Sakamoto, Y1
Ito, S1
Morita, M1
Kawai, M1
Yamashita, Y1
Ito, K1
Yamada, H1
Shima, H1
Yaegashi, N1
Tanuma, N1
Mume, E1
Orlova, A1
Malmström, PU1
Lundqvist, H1
Sjöberg, S1
Tolmachev, V1
Makutova, SV1
Plikhtiak, IL1
Iartseva, IV1
Ivanova, TP1
Mel'nik, SIa1

Other Studies

3 other studies available for niacin and Ovarian Neoplasms

ArticleYear
Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer.
    FEBS letters, 2020, Volume: 594, Issue:9

    Topics: Acrylamides; Cell Line, Tumor; Cytokines; Female; Glycolysis; Humans; Lactic Acid; NAD; Niacin; Nico

2020
Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET.
    Nuclear medicine and biology, 2005, Volume: 32, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bromine Radioisotopes; Cell Line, Tumor;

2005
[Modification of pyrimidine nucleosides using nicotinic acid derivatives].
    Bioorganicheskaia khimiia, 1995, Volume: 21, Issue:4

    Topics: Antineoplastic Agents; Female; Humans; Magnetic Resonance Spectroscopy; Niacin; Ovarian Neoplasms; P

1995